Obstructive Hypertrophic Cardiomyopathy research hub

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

This study looks at how people with a heart condition called obstructive hypertrophic cardiomyopathy (HCM) are treated in real life. It compares a new medicine called mavacamten with other treatments, focusing on how patients feel and how their condition progresses over time.